Self-performing immunochromatographic device

• US 5,075,078 A
• Filed: 10/05/1989
• Issued: 12/24/1991
• Est. Priority Date: 10/05/1989
• Status: Expired due to Term

• Current Assignee: Inverness Medical Switzerland GmbH (Abbott Laboratories)
• Original Assignee: Abbott Laboratories
• Inventors: Richerson, Russell B., Walsworth, Frank, Beggs, Michael, Brookhart, Paul, Osikowicz, Eugene W.
• Primary Examiner(s): Warden, Robert J.
• Assistant Examiner(s): Soderquist, Arlen
• Application Number:
  US07/417,346
• Time in Patent Office: 810 Days
• Field of Search: 422/56, 436/162, 436/169, 436/530
• US Class Current: 422/420
• CPC Class Codes: G01N 33/54366 Apparatus specially adapted for solid-phase testing
• CPC Class Codes: G01N 33/54386 Analytical elements
• CPC Class Codes: G01N 33/54388 based on lateral flow
• CPC Class Codes: G01N 33/558 using diffusion or migration of antigen or antibody immunochromatographic test strips G01N33/54387

Abstract

Improved chromatographic strip binding assay devices are provided for determining the presence or amount of an analyte present in a patient sample. Assay label reagents interact with capture reagents immobilized in a testing region on the strip substrate to generate a visually detectable image indicative of the test result. The test result images include a minus sign (-) to indicate a negative test result for analyte which image is generated if the suspect analyte is absent in the patient sample and a plus sign (+) to indicate a positive test result for analyte which image is generated if the suspect analyte is present or is present at a pre-determined concentration in the patient sample. The immobilized capture reagents responsible for the location and configuration of the test result images are applied to the strip at an angled orientation with respect to the fluid flow direction of the strip to ensure that sharp substantially complete test result images are formed during performance of the assay. The devices provide substantially self-performing assays having inherently clear test results which are not subject to misinterpretation by the skilled or untrained user.

Claims

1. In a chromatographic strip binding assay device, for detecting the presence or amount of an analyte in a patient sample, wherein a visually detectable plus sign (+) develops to indicate a positive test PG,38 result or a visually detectable minus sign (-) develops to indicate a negative test result, the device comprising:

a chromatographic strip having a length and narrow width capable of conveying fluids in a fluid flow direction generally parallel to the length of said strip, said strip comprising

a sample contact region whereat a fluid patient sample and other assay reagents may be contacted with said strip, and

a testing region disposed on said strip at a downstream location from said sample contact region, said testing region comprising

a patient test bar defined by a first capture reagent, specific for the analyte, immobilized on said strip in a generally rectangular configuration, and

a procedural control bar defined by a second capture reagent, specific for an assay label, immobilized on said strip in a generally rectangular configuration, said patient test bar and said procedural control bar intersecting each other in a generally perpendicular manner;

wherein the the testing region improvement comprises;

said patient test bar and said procedural control bar each being immobilized on said strip in an angled orientation with respect to the fluid flow direction of said strip to minimize the distance travelled by an added migrating fluid across both said patient test bar and said procedural control bar.

2. A device as in claim 1, wherein the angular orientations of said patient test bar and said procedural control bar with respect to the fluid flow direction are defined by complementary angles varying between about 30°

to about 60°

, respectively.

3. A device as in claim 1, wherein the angled orientation of said patient test bar and said procedural control bar with respect to the fluid flow direction is about 45°

, respectively.

4. A device as in claim 1, wherein said chromatographic strip substrate comprises nitrocellulose.

5. A device as in claim 1, wherein said first capture reagent comprises a specific binding pair member for analyte.

6. A device as in claim 5, wherein said first capture reagent is selected from the group comprising an antigen or an antibody.

7. A device as in claim 1, wherein said second capture reagent comprises a specific binding pair member for said assay label.

8. A device as in claim 7, wherein said second capture reagent is selected from the group comprising an antigen or an antibody.

9. A device as in claim 1, further comprising a housing for surrounding and holding said strip, said housing comprising:

a sample entry aperture disposed adjacent said sample contact region of said strip, and a test result window disposed adjacent said testing region of said strip.

10. A device as in claim 1, further comprising a conjugate pad comprising a porous pad substrate, having said assay label therein, disposed adjacent said strip at said sample contact region.

11. A device as in claim 10, wherein said first capture reagent comprises an antibody specific for the analyte, said second capture reagent comprises immobilized analyte, and said assay label in said conjugate pad comprises an antibody, specific for the analyte, conjugated to a labelling substance.

12. A device as in claim 11, wherein said labelling substance is a selenium colloid label.

13. A device as in claim 11, wherein said second capture reagent comprises an immobilized antibody/analyte complex.

14. A device as in claim 10, wherein said first capture reagent comprises an antibody specific for the analyte, said second capture reagent comprises an antibody specific for said assay label, and said assay label comprises an antibody, specific for the analyte, conjugated to a labelling substance.

15. A device as in claim 14, wherein said labelling substance is a selenium colloid label.

16. A device as in claim 14, wherein said assay label comprises a monoclonal antibody from a first species specific for the analyte being tested for and said second capture reagent comprises an antibody from a second species specific for the monoclonal antibody of the first species.

17. A device as in claim 16, wherein said assay label comprises a mouse monoclonal antibody specific for the analyte, and said second capture reagent comprises an anti-mouse IgG antibody.

18. A device as in claim 1, further comprising an end of test indicator region on said strip at a downstream location from said testing region and defined by an indicator reagent capable of generating a visually detectable signal upon contact with testing fluids to indicate that fluids have flowed to said end of test indicator region and that the test result indicated at said testing region is a final test result.